Investegate |RUA Life Sciences Announcements | RUA Life Sciences: Directorate Changes
Directorate Changes RUA Life Sciences, the holding company of a group of medical device businesses focused on the exploitation of the world's leading long-term implantable biostable polymer (Elast-Eon TM), is pleased to announce the appointments, with immediate effect, to the Board of Dr Caroline Stretton, Group Chief Operating Officer of the Company, and Ian Ardill as a Non-Executive Director and Chair of the Audit Committee. Dr Caroline Stretton who was appointed as Group Chief Operating Officer on 1 April 2020, following the Company's acquisition of RUA Medical ...